Blood thinners, diabetes meds among first 10 drugs for US price negotiations
www.reuters.com
The Biden administration on Tuesday released its list of 10 prescription medicines that will be subject to the first-ever price negotiations by the U.S. Medicare health program that covers 66 million people, with blood thinner Eliquis from Bristol Myers Squibb and Pfizer among them.
  • TH1NKTHRICE@lemmy.ca
    3·
    1 year ago

    The drugs selected to undergo negotiations are:

    • Eliquis, a blood thinner
    • Xarelto, a blood thinner
    • Januvia, a diabetes drug
    • Jardiance, a diabetes drug
    • Enbrel, a rheumatoid arthritis drug
    • Imbruvica, a drug for blood cancers
    • Farxiga, a drug for diabetes, heart failure and chronic kidney disease
    • Entresto, a heart failure drug
    • Stelara, a drug for psoriasis and Crohn’s disease
    • Fiasp and NovoLog, for diabetes

    (via NBC)

  • TheaoneAndOnly27@kbin.social
    0·
    1 year ago

    There are a lot of comments in here pointing out how those are older people medication. I’m 33 and I’ll be on eliquis for the rest of my life. Without good insurance it’s over 600 bucks a month. This is phenomenal news for my future, and for my safety. While the vast majority is medications will impact the over 65 category, there are a lot of us who are still taking these too.